Lactate dehydrogenase (LDH) is an enzyme that plays a crucial role in cellular respiration, converting lactate to pyruvate. LDH is found in various tissues throughout the body, and its levels in the blood can be measured to assess cell damage and various medical conditions. Several companies produce LDH test kits and related products for diagnostic purposes.
Latest Lactate dehydrogenase test Companies Update
Jan 2023: The premier global holding company that unites top antibody-centric businesses, Absolute Biotech, was formed by combining LifeSpan Biosciences, a TSCP portfolio company, into a single entity. This announcement was made by St. Louis-based private equity firm Thompson Street Capital Partners (TSCP). Absolute Biotech is a company that specializes in antibody reagents and services. The company adds value to pre-existing antibodies, reagents, and kits through engineering, recombinant production, annotation, validation, and sequencing. The merged business will use the distinct antibody expertise of each brand to promote the development and accessibility of highly specialized life science reagents. In 2018, TSCP purchased LifeSpan Biosciences. Absolute Biotech provides clients worldwide with a range of antibody-related goods, services, and know-how for therapeutic, diagnostic, and research applications. The company makes sequence-defined, repeatable reagents more broadly available for immunohistochemistry and other important applications by combining a robust range of recombinant antibodies with experience in antibody engineering specific to the application validation.
Jul 2023: Quest Diagnostics unveiled the first direct-to-consumer blood test to detect abnormal levels of beta-amyloid, a critical protein linked to Alzheimer's disease that can appear years before dementia symptoms. The AD-Detect test uses the same technology as a blood test that the company introduced for medical practitioners in early 2022. The announcement follows the earlier this month full regulatory approval of Leqembi, a drug co-developed by Eisai and collaborator Biogen that has been shown to slow the course of Alzheimer's in those with the illness in its early stages. The company makes sequence-defined, repeatable reagents more broadly available for immunohistochemistry and other important applications by combining a robust range of recombinant antibodies with experience in antibody engineering and application-specific validation.
Lactate Dehydrogenase Test Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)